Home » cGMPs Regulatory Compliance » cGMPs Regulatory Compliance » Mandatory Reporting is the Key to Eradicating Counterfeit Drugs
Mandatory Reporting is the Key to Eradicating Counterfeit Drugs
Overview:
Numbers are bandied about on the extent of counterfeiting, but these figures are probably low. By how much? Will we ever know? Closer connection between government and industry, and ongoing reporting, will be essential in finding out, say the authors.
Author: Robert Cockburn, Paul N. Newton, E. Kyeremateng Agyarko, Dora Akunyili, Nicholas J. White | File Type: PDF
Find more white papers on Process Operations, Quality Assurance Control, Packaging
More content on this topic:
Get Connected Now!
- Featured White Papers

Print page